hemophilia B
英
美 [ˌhiməˈfiliə biː]
【医】血友病B:缺乏凝血因子Ⅸ所致。见factor项下的coagulation factors
双语例句
- Progressions of gene therapy studies for hemophilia B were introduced in this paper.
就血友病B的基因治疗研究进展及所存在的问题作一综述。 - The bio-therapy and gene-therapy of hemophilia B in China
中国血友病B生物基因治疗研究状况 - The F ⅸ∶ Ag of the plasma in patient with severe hemophilia B were tallied with clinical diagnosis.
重症乙型血友病人血浆FⅨ∶Ag测得值与临床诊断相符。 - Gene Therapy for Hemophilia B
血友病B的基因治疗 - The clinical trial of gene therapy on four hemophilia B patients
四例血友病B患者基因治疗的临床试验 - The gene frequencies were 0.19.The female heterozygous showed all four bands and the frequencies were 0.31.The new polymorphism seems to be useful for carrier detection and prenatal diagnosis of hemophilia B in Chinese population.
该发现有利于我国血友病B携带者筛查和产前基因诊断。 - The Construction and the Study of Expression Retroviral Vector of Gene Therapy for Hemophilia B by Muscle Cells
肌细胞途径血友病B基因治疗高表达载体的构建及表达研究 - Safety assessments required for animal test and preclinical trial of hemophilia B gene therapy
血友病B基因治疗临床试验的安全性研究 - Study on Gene Mutations of Factor ⅸ Gene of Hemophilia B Patients from China
27例乙型血友病患者Ⅸ因子基因突变研究 - Study on mutations in hemophilia B patient factor ⅸ gene
血友病B基因突变的研究 - Establishment of a Hemophilia B Transgenic Mouse Model on the Basis of Coagulation Factor ⅸ Gene Knock-out Mouse
基于凝血因子Ⅸ基因剔除小鼠建立血友病乙转基因动物模型 - Intron I has been successfully used as virus vector to improve expression of FIX in the research of gene therapy for hemophilia B. In our research, intron I is targeted to ordinary vector and human source gene vector.
在血友病B基因治疗的研究中，已有人将hFIX基因的内含子I用于病毒载体来提高FIX的表达量，并取得了一定的成效。 - A 29 year old woman with a family history of hemophilia B asked for prenatal diagnosis in the 8th week of pregnancy.
一例有血友病B家族史的29岁孕妇，于妊娠8周时要求对胎儿进行诊断。 - Hemophilia B is a X chromosome-linked recessive bleeding disorder which results from a deficiency in the coagulation factor IX.
血友病B是X-连锁的隐性遗传疾病，是由于凝血因子IX缺乏引起。 - Prenatal diagnosis of hemophilia B by factor IX gene analysis
血友病B的产前基因诊断 - Rabbit experiments and related safety assessment study of gene transfer therapy for hemophilia B
基因转移治疗血友病B的动物试验和安全性探讨 - Some genetic diseases, such as hemophilia B, are partly caused by a given point mutation.
一些遗传性疾病，如乙型血友病，有部分是由于Ⅸ因子核苷酸序列中特定位点点突变引起的。 - In this study, long-term, high-level expression of FIX mediated by recombinant AAV vectors in hemophilia B mice was reported. The bleeding symptom of the treated mice was significantly ameliorated.
本研究采用重组AAV为载体，使凝血因子IX基因在血友病B小鼠体内高效、长期稳定地表达，从而改善小鼠的出血症状，提高各项凝血指标，为今后的临床试验打下了基础。 - All of 10 hemophilia B families were made final diagnosis by using 6 extragenic loci of factor ⅸ respectively.
联合FⅨ基因外6个STR位点对血友病B家系进行遗传连锁分析，使10个家系全部得到诊断。 - DXS102 locus can be used as a promising marker for gene diagnosis in hemophilia B family.
结论DXS102座位连锁分析有望成为一种有效的血友病B基因诊断的方法。 - Clinical studies on gene therapy for hemophilia B
血友病乙基因治疗临床研究 - Studies on the Phenotype and Genetic Stability of Coagulation Factor ⅸ-deficient Mouse Model for Human Hemophilia B
凝血因子Ⅸ基因剔除小鼠遗传稳定性及其临床表型研究 - Hemophilia B is an X chromsome-linked recessive factor IX ( hFIX) deficiency bleeding disorder occurring 1 in 30,000 males.
（一）血友病B是血浆凝血IX因子缺乏所导致的X连锁隐性出血性遗传病，在男性患病率约为三万分之一。 - Objective To study the mechanism of molecular defect of factor ⅸ( F ⅸ) in hemophilia B patient.
目的为了研究血友病B因子Ⅸ（FⅨ）分子缺陷的发生机制。 - Objective: To develop experimentally gene therapy for hemophilia B by using C2C12 cells and C3H mice as models.
目的：以小鼠C2C12成肌细胞为对象开展血友病乙基因治疗研究。